EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
13 hedge funds and large institutions have $11.4M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$28K | |
| 2 | +$24.2K | |
| 3 | +$8K | |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$2.19K |
Top Sellers
| 1 | -$860K | |
| 2 | -$794K | |
| 3 | -$3.93K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |